Banner Location Image
Request Free Consultation
Posted on April 18, 2012

Overdose risk prompts morphine syringe recall

The United States Food and Drug Administration in, cooperation with the Stericycle pharmaceutics manufacturing company, has issued a safety recall for a single lot of Carpuject morphine syringes after reports that two of the syringes from this lot contained more morphine than their labeled fill volume  of 1 milliliter. A morphine overdose can cause potentially… read more

Read Article
Posted on March 29, 2012

Three Indian drug manufacturers announce U.S. recalls

Sun Pharmaceuticals, thebiggest drug manufacturer in India, has announced a voluntary recall of approximately 1.55 million  units of eye solution in the United States, due to  an impure medicine formula,  according to the United States Food and Drug Administration.  The eye solution, used to treat conjunctivitis, was discovered to contain impurities that were not up… read more

Read Article
Posted on March 23, 2012

Sandoz recalls 57,000 vials of injectable morphine

Sandoz Canada Incorporated has issued a voluntary recall for approximately 57,000 vials of injectable morphine due to a possible health hazard created by improper packaging. The pharmaceutics manufacturer, headquartered in Quebec, became aware of a packaging error after a Toronto hospital found four vials of an adrenaline-type heart drug known as isoproterenol hydrochloride inside a… read more

Read Article
Posted on March 20, 2012

High blood-pressure drug Apo-Ramipril recalled

Apotex Incorporated has issued a voluntary recall for one lot of its hypertension treatment drug Apo-Ramipril 5mg Capsules. This recall has been issued to retail businesses throughout Canada. The recall of the Apo-Ramipril 5mg Capsules in Lot JR2178 is due to the fact that the capsules are sealed and empty of any medication. Health Canada… read more

Read Article
Posted on March 8, 2012

Bedford Labs Recalls Three Lots of Leukemia Fighting Drug

A recall has been announced for an item that there’s already a shortage of thanks to a variety of other recalls. Bedford Laboratories out of Ohio has issued a voluntary recall for three lots of cytarabine.  This is used in the treatment of leukemia, and is a particularly popular chemotherapy drug due to its irreplaceability… read more

Read Article
Posted on February 29, 2012

Recall: GlaxoSmithKline Drug Packaged In Nebraska

According to news sources, a recall has recently been announced by GlaxoSmithKline for a drug packaged in Nebraska. The recall affects about 400,000 bottles of a blood pressure drug called DynaCirc CR, which was packaged in Nebraska at a Novartis plant. The plant is reportedly manufacturing the generic drug on a contract basis. There have… read more

Read Article
Posted on February 6, 2012

Numerous Diet Supplements Recalled Over Presence of Drugs

A number of dietary supplement products have been recalled by Healthy People Company because Food and Drug Administration testing revealed that they contained Sibutramine and Tadalafil.  The products, all dietary supplements, are Mince Belle, PERFECT Men, EVERLAX, EVER Slim, Herbal Drink Acai-Man Mangosteen, EVER SLIM Strawbbery Shake Mix, and EVER SLIM Chocolate Shake Mix. The… read more

Read Article
Posted on January 24, 2012

Johnson & Johnson Earnings Low Due To Recalls

In a show of just how much damage a product recall can do to a bottom line, Johnson and Johnson has been reported to have taken charges of $3 billion, and their earnings forecast for 2012 is below previous projected numbers. In 2010, the company’s DePuy Orthopedics Division announced a recall of their “metal-on-metal” hip… read more

Read Article
Posted on November 10, 2011

Drug Recalls More Frequent than Ever

According to related news articles, the number of drug recalls is higher and higher every year. Allegedly, the pharmaceutical recalls jumped to 150 in the third quarter of 2010 alone. Details from the FDA Enforcement Reports show that the spike in drug recalls may have something to do with the aggressive activity from FDA authorities… read more

Read Article
Posted on November 1, 2011

Possible Bacterial Contamination behind Nostrilla Recall

The FDA along with the Insight Pharmaceuticals, LLC have issued a recall for the Nostrilla Nasal Decongestant due an alleged Bacterial Contamination. News reports from the U.S. Food and Drug Administration show that consumers who purchased “Nostrilla Decongestant” from the 11G075 lot should return the product immediately. The product has been distributed Nationwide and there isn’t an… read more

Read Article
Posted on October 20, 2011

Nasal Decongestant Containing Bacteria Recalled

A nasal decongestant has been recalled by Insight Pharmaceuticals after it was found the spray may contain bacteria, according to recent news sources. About 34,092 bottles of Nostrilla are subject to recall. The product, which contains oxymetazoline, is used to relieve nasal suffering from colds. The bacteria is called Burkholderia cepacia and is especially dangerous… read more

Read Article
Posted on October 6, 2011

Drug Recalled After Tests Revealed Banned Ingredient

Uprizing 2.0, a drug made by Superior Metabolic Technologies Inc, has been recalled due to the presence of an undeclared, banned ingredient, according to recent news sources. Uprizing is a testosterone booster that was found to contain superdrol, a synthetic steroid that is currently banned. Users of synthetic anabolic steroids have been known to sustain… read more

Read Article

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields